City

Beijing (1)

Buffalo (1)

Rochester (1)

Overall Status

Recruiting (2)

Completed (1)

Phase

early phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Mayo Clinic (1)

Peking University People's Hospital (1)

Roswell Park Cancer Institute (1)

Collaborator

National Cancer Institute (NCI) (1)

Peking University Shougang Hospital (1)

Intervention

cisplatin (2)

cytoreductive surgery (1)

doxorubicin (1)

hyperthermic intraperitoneal chemotherapy (1)

isolated chemotherapeutic lung perfusion (1)

metastasectomy (1)

radiotherapy group (1)

resection group (1)

sodium thiosulfate (1)

Study Documents

Intervention Type

procedure (3)

drug (2)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

resectable sarcoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Metastatic Bone Sarcoma, Metastatic Malignant Tumor in the Lung, Metastatic Soft Tissue Sarcoma Trial in Buffalo (Cisplatin,

Recruiting

Metastatic Bone Sarcoma
+5 more

Cisplatin
+2 more

Buffalo, New York

Roswell Park Cancer Institute

Jan 24, 2023

Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive

Recruiting

Malignant Abdominal Neoplasm
+26 more

Cisplatin
+4 more

Rochester, Minnesota

Mayo Clinic in Rochester

Jan 5, 2023

Osteosarcoma With Resectable Pulmonary Metastasis: A

Completed

Osteosarcoma Metastatic
+3 more

resection group
radiotherapy group

Beijing, Beijing, China
+1 more

Dec 3, 2020